Method of treatment of rheumatoid arthritis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 9, 1982
Issued Date -
N/A
app pub date -
Sep 18, 1979
filing date -
Dec 22, 1978
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Rheumatoid arthritis is treated with substituted cysteine compounds having a lower toxicity-to-effectiveness ratio than penicillamine. Such compounds are specific alpha-substituted cysteines, beta-monosubstituted cysteines, beta-di-substituted cysteines other than penicillamine, N-acetyl penicillamine and the N-acetyl derivatives of the alpha and beta-substituted compounds mentioned above. Any of the compounds may be used synergistically in combination with suitable copper compounds or with suitable gold compounds in the treatment of arthritis. The same compounds are effective in the treatment of cystinuria and heavy metal poisoning. The same compounds are well as penicillamine are effective in combination with copper in the treatment of heavy metal poisoning.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully